Investor
SOSV
1Undisclosed—0
Startups backed by SOSV that were acquired: 1 exit so far, with the buyer, the price where disclosed and every source.
Image: SynPlexityAzenta acquires University of Oregon gene synthesis spinout SynPlexity
The life sciences group bought the Eugene startup, which builds thousands of full-length gene variants in a single library, to expand its GENEWIZ gene synthesis business. It also took an exclusive licence to Elegen's cell-free DNA technology.
Undisclosedn/aSeedCorporate
Latest in SOSV
All SOSV exitsOpen tracker →
Azenta → SynPlexityUndisclosedUndisclosed